CTNNB1 and neoplasm: In vitro and in vivo results of this study suggested that CLCA1 plays a key role as a tumor suppressor in CRC by suppressing the epithelial–mesenchymal transition (EMT) and Wnt/beta-catenin signaling pathway [31].